Matrix metalloproteinases 2, 3, 13 and their type 2 tissue inhibitor in tumors and plasma of patients with colorectal cancer

Enzyme immunoassay studies revealed increased content of matrix metalloproteinases 2, 3 and 13 in tumors compared to the adjacent histologically unchanged mucosa in 70–90% patients with colorectal cancer, while the increase in the content of type 2 metalloproteinase tissue inhibitor did not reach th...

Ausführliche Beschreibung